| Literature DB >> 31333879 |
Abstract
PURPOSE: To measure the choroidal thickness in patients with high myopia from staphyloma using swept source OCT (SS-OCT) in Early Treatment Diabetic Retinopathy Study (ETDRS) fields and compare to normal cohort. The study also evaluated the correlation between choroidal thickness with axial length and best-corrected visual acuity (BCVA).Entities:
Keywords: Choroidal thickness; Staphyloma; Swept source optical coherence tomography
Year: 2019 PMID: 31333879 PMCID: PMC6615153 DOI: 10.1186/s40942-019-0166-y
Source DB: PubMed Journal: Int J Retina Vitreous ISSN: 2056-9920
Fig. 1Schematic representation of nine ETDRS segments (a) and its overlay over the retinal surface (b) along with choroidal thickness for each field. c The lines demarcating the choroido-scleral junction and Bruchs choriocapillaris complex
Comparable baseline demographics between the normal subjects and staphyloma subjects
| Parameters | Normal subjects (86 eyes) | Staphyloma subjects (37 eyes) |
|---|---|---|
| Age | ||
| Mean | 40.28 years | 45.68 years |
| Median | 36 years | 46 years |
| Range | 21–70 years | 14–79 years |
| LogMAR BCVA | 0.0–0.1 | 0–1.3 |
| Axial length (in mm) | 21.79–23.89 | 25.12–33.82 |
| Sex ratio (male:female) | 20:23 | 9:11 |
| Race | Asian—13 | Asian—3 |
| Caucasian—18 | Caucasian—10 | |
| African American—12 | African American—7 | |
BCVA best corrected visual acuity
Mean choroidal thickness in nine ETDRS subfield in normal subjects
| Parameters | Mean choroidal thickness | |||
|---|---|---|---|---|
| Total cohort | OD ( | OS ( | ||
| CSF | 250.24 ± 71.01 (96–401) | 252.30 ± 72.10 (96–401) | 248.17 ± 69.81 (121–376) | > 0.05 |
| Tl | 255.34 ± 66.42 (129–395) | 255.65 ± 68.46 (129–395) | 255.14 ± 65.13 (137–388) | > 0.05 |
| TO | 249.17 ± 58.61 (151–404) | 247.93 ± 58.34 (151–396) | 250.42 ± 59.53 (155–404) | > 0.05 |
| SI | 263.02 ± 69.45 (122–402) | 265.32 ± 68.99 (122–396) | 260.72 ± 70.7 (122–402) | > 0.05 |
| SO | 263.73 ± 65.30 (127–387) | 264.77 ± 66.60 (127–387) | 262.70 ± 64.8 (146–387) | > 0.05 |
| NI | 243.31 ± 71.64 (89–393) | 244.74 ± 69.8 (89–383) | 241.36 ± 73.6 (94–382) | > 0.05 |
| NO | 208.91 ± 70.10 (60–375) | 209.44 ± 67.51 (60–358) | 206.67 ± 72.51 (78–375) | > 0.05 |
| II | 255.34 ± 72.34 (100–438) | 259.79 ± 75.06 (100–438) | 250.88 ± 69.12 (103–384) | > 0.05 |
| IO | 257.98 ± 71.03 (103–443) | 260.67 ± 71.89 (121–443) | 255.27 ± 70.84 (103–395) | > 0.05 |
OD right eye, OS left eye, CSF central sub-field, SI superior inner, NI nasal inner, II inferior inner, TI temporal inner, SO superior outer, NO nasal outer, IO inferior outer, TO temporal outer
Mean choroidal thickness in nine ETDRS subfield in staphyloma patients
| Parameters | Mean choroidal thickness | |||
|---|---|---|---|---|
| Total cohort | OD ( | OS ( | ||
| CSF | 78.19 ± 45.07 (11–153) | 70.40 ± 39.57 (11–123) | 85.53 ± 48.61 (11–153) | > 0.05 |
| TI | 88.81 ± 49.36 (22–186) | 84.05 ± 43.86 (25–168) | 93.31 ± 51.44 (22–186) | > 0.05 |
| TO | 96.83 ± 48.44 (26–181) | 91.27 ± 43.46 (26–159) | 98.10 ± 49.13 (28–181) | > 0.05 |
| SI | 88.14 ± 44.13 (20–151) | 77.0 ± 39.38 (21–141) | 93.16 ± 47.07 (20–151) | > 0.05 |
| SO | 87.43 ± 47.74 (13–178) | 80.50 ± 44.97 (13–169) | 90.00 ± 50.42 (19–178) | > 0.05 |
| NI | 75.59 ± 40.66 (19–165) | 71.50 ± 40.91 (19–165) | 79.47 ± 40.04 (21–162) | > 0.05 |
| NO | 57.32 ± 30.22 (13–152) | 52.55 ± 29.03 (13–146) | 61.84 ± 30.73 (20–152) | > 0.05 |
| II | 87.16 ± 44.57 (15–153) | 82.22 ± 41.74 (25–142) | 91.84 ± 46.60 (15–153) | > 0.05 |
| IO | 86.97 ± 44.51 (30–171) | 87.00 ± 45.11 (31–171) | 86.94 ± 43.94 (30–158) | > 0.05 |
OD right eye, OS left eye, CSF central sub-field, SI superior inner, NI nasal inner, II inferior inner, TI temporal inner, SO superior outer, NO nasal outer, IO inferior outer, TO temporal outer
Fig. 2Choroidal thickness in the nine ETDRS segments in patients with staphyloma (a) and normal subjects (b)
Fig. 3Correlation between central subfield choroidal thickness and axial length in entire cohort (n = 123 eyes)
Fig. 4Correlation between central subfield choroidal thickness and log MAR best corrected visual acuity (BCVA) in entire cohort (n = 123 eyes)
Fig. 5Correlation between delta value (difference between the mean choroidal thickness and actual value) of choroidal thickness and axial length in patients with staphyloma (37 eyes)
Fig. 6Correlation between delta value (difference between the mean choroidal thickness and actual value) of choroidal thickness and logMAR best corrected visual acuity (BCVA) in patients with staphyloma (37 eyes)
Fig. 7Correlation between central subfield (CSF) choroidal thickness and axial length in staphyloma subjects (37 eyes) (r = − 0.83, r2 = 0.67, p < 0.0001)
Fig. 8Correlation between central subfield choroidal thickness and logMAR best corrected visual acuity (BCVA) in staphyloma subjects (37 eyes), r = − 0.60; r2 = 0.35, p < 0.001